NCT05192122
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Illinois Cancer Center Chicago, Illinois, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,146 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
NCT06736613
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, +21 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
NCT07062627
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Asan Medical Center Seoul, South Korea
NCT05171478
- Conditions
- Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +12 more
- Locations
-
- Johns Hopkins Hospital Baltimore, Maryland, United States
NCT06387121
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Recruiting
Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies
NCT07284927
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT07285590
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Instituto Português de Oncologia de Lisboa Francisco Gentil Lisbon, Lisbon District, Portugal
- Unidade Local De Saude De Santa Maria E.P.E. Lisbon, Lisbon District, Portugal
- INSTITUT CATALÀ D'ONCOLOGIA (ICO). Hospital Germans Trias I Pujol. Badalona, Barcelona, Spain
- Hospital Universitari Vall d'Hebron Barcelona, Spain
NCT07189065
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Anhui Cancer Hospital (West Branch of Anhui Provincial Hospital) Hefei, Anhui, China
- Beijing Shijitan Hospital Beijing, Beijing Municipality, China
- Beijing Tongren Hospital Beijing, Beijing Municipality, China
- National Cancer Center/Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
NCT05901974
- Conditions
- Acute Leukemia of Ambiguous Lineage, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- The First Affliated Hospital of Soochow University Suzhou, China
Recruiting
Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT06757647
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +14 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States